Sorrento Therapeutics Inc (SRNE) stock has gained 412.15% over the last 12 months, and the average rating from Wall Street analysts is a Strong Buy. InvestorsObserver’s proprietary ranking system, gives SRNE stock a score of 78 out of a possible 100.
That rank is mainly influenced by a long-term technical score of 92. SRNE's rank also includes a fundamental score of 85. In addition to the average rating from Wall Street analysts, SRNE stock has a mean target price of 24. This means analysts expect the stock to climb 118.98% over the next 12 months. The short-term technical score for SRNE is 57.
What's Happening with SRNE Stock Today
Sorrento Therapeutics Inc (SRNE) stock is higher by 7.98% while the S&P 500 is unchanged 0% as of 10:45 AM on Tuesday, Sep 29. SRNE has gained $0.81 from the previous closing price of $10.15 on volume of 18,525,849 shares. Over the past year the S&P 500 is up 12.59% while SRNE has gained 412.15%. SRNE lost -$1.61 per share in the over the last 12 months.